Arpelos Biosciences is a seed-stage biotechnology company based in Kendall Square, Cambridge, developing multivalent medicines — therapeutics engineered for high potency and selectivity by engaging multiple targets or sites simultaneously. The founding team comprises scientists from UCSF, Penn, Stanford, and MIT spanning computational biology, immunology, and protein engineering, and the company is backed by prominent biotech investors including Wing Venture Capital. Arpelos currently operates as a stealth-stage research company with a single-page web presence and does not publish a public API, developer portal, SDKs, or technical documentation; this profile is maintained in the API Evangelist network as a company identity record awaiting any future developer surface.
Arpelos Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Drug Discovery.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: arpelos-biosciences
name: Arpelos Biosciences
description: Arpelos Biosciences is a seed-stage biotechnology company based in Kendall Square, Cambridge, developing multivalent
medicines — therapeutics engineered for high potency and selectivity by engaging multiple targets or sites simultaneously.
The founding team comprises scientists from UCSF, Penn, Stanford, and MIT spanning computational biology, immunology, and
protein engineering, and the company is backed by prominent biotech investors including Wing Venture Capital. Arpelos currently
operates as a stealth-stage research company with a single-page web presence and does not publish a public API, developer
portal, SDKs, or technical documentation; this profile is maintained in the API Evangelist network as a company identity
record awaiting any future developer surface.
url: https://raw.githubusercontent.com/api-evangelist/arpelos-biosciences/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: Arpelos currently operates as a stealth-stage research company with a single-page web presence and does
not publish a public API, developer portal, SDKs, or technical documentation; this profile is ma
x-type: company
x-source: vc-portfolio
x-backed-by:
- wing-venture-capital
x-tier: stub
x-tier-reason: portfolio-lead
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Life Sciences
- Therapeutics
- Drug Discovery
- Protein Engineering
- Computational Biology
image: https://www.arpelos.com/favicon.ico
apis: []
common:
- type: Website
url: https://www.arpelos.com
- type: DomainSecurity
url: security/arpelos-biosciences-domain-security.yml
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-07-19'
status: backfilled
pass: local-v1
note: backfilled from .gitignore signal + verified work evidence
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →